Investigatorerne blev instrueret i at titrere forsøgsmedicinen til 100 mg én gang dagligt, hvis dette var relevant; 72% af patienterne fik 100 mg dagligt det meste af tiden.
Investigators were instructed to titrate the study medication to 100 mg daily as appropriate; 72% of patients were taking the 100 mg daily dose for the majority of the time.